Key Highlights

  • SCWorx (NASDAQ:WORX) traded at USD 2.04, up 6.81%, in pre-market trading on Wednesday, October 28, 2026. No announcement dated that day or the day before was identified, and the latest one was dated Monday, October 19, 2026.
  • Unaudited revenue for the first half of 2026 was about USD 1.45 million, compared with about USD 1.40 million a year earlier. Gross profit climbed about 122% to USD 705,000, and the net loss narrowed to about USD 295,000 from USD 2.4 million.
  • Nasdaq approved continued listing on Friday, October 2, 2026 under a Panel Monitor that runs through Saturday, October 2, 2027. Trading resumed on Wednesday, October 7, 2026.
  • Only 549,092 publicly held shares were outstanding on Thursday, September 17, 2026, so liquidity is thin. The pre-market price is a snapshot that can change before the open.

Pre-Market Move and Its Trigger

SCWorx (NASDAQ:WORX) supplies data management and normalisation services to healthcare supply chains. Its USD 2.04 pre-market quote, up 6.81%, arrived on Wednesday, October 28, 2026, which made it a second straight pre-market gain. Prices can move again before the 9:30 a.m. ET open. Nothing dated that day or the day before explained the rise. The most recent release, from Monday, October 19, 2026, described a fresh agreement with an independent, community-owned health system serving New Mexico, Arizona, Colorado and Utah. The terms were not disclosed. Continued interest after trading resumed, together with thin liquidity, fits the move, but both are inferences rather than confirmed causes.

How the First Half Figures Frame the Move

The first half numbers matter because they show a business edging toward breakeven on small sales. The release of Wednesday, October 7, 2026 gave unaudited revenue of about USD 1.45 million for the first half of 2026, against about USD 1.40 million. Gross profit rose roughly 122% to USD 705,000. The net loss shrank to about USD 295,000 from USD 2.4 million, and cash used in operations dropped to about USD 258,000 from USD 1.1 million. Cash stood at about USD 1.3 million on Tuesday, June 30, 2026. A placement of Thursday, September 17, 2026 sold 350,000 units at USD 2.68, raising gross proceeds of about USD 938,000. The warrants carry an exercise price of USD 2.56, and the proceeds stay in a segregated account until Monday, November 30, 2026.

Risks and Signals to Track

The optimistic view rests on a much smaller loss, higher gross profit and a listing that was restored after a suspension of Tuesday, April 14, 2026 for falling short of the USD 1.00 minimum bid. The pessimistic view rests on revenue that is nearly flat, modest cash and a float of 549,092 shares, which sits close to the 500,000 minimum. Other named risks include dilution from the warrants, a fresh bid price breach during the monitor period and reliance on a handful of healthcare customers. Closing bids have been at or above USD 1.00 since Tuesday, August 4, 2026. Investors should watch the release of the segregated proceeds on Monday, November 30, 2026, the third quarter report, which has no date yet, and the Federal Reserve decision due later on Wednesday, October 28, 2026.

Where Things Stand

The short answer is that SCWorx (NASDAQ:WORX) can hold its 6.81% pre-market gain only if trading stays supportive. No dated announcement explains the move, and the float is small. The headline figure is first half gross profit of about USD 705,000, up roughly 122%, while the net loss was about USD 295,000. The next checkpoints are the release of segregated proceeds on Monday, November 30, 2026, the third quarter report with no date set, and the Federal Reserve decision due later on Wednesday, October 28, 2026. Pre-market prices are snapshots and can change, and this is not investment advice.